News Medical on MSN8h
Grifols receives grant for early Parkinson's disease biomarker discoveryGrifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...
Hosted on MSN10h
Herbicide under US scrutiny over potential Parkinson's linkFirst came the slow hand movements, then the tremor, and now the looming fear of what lies ahead. By the end of the decade, ...
ScienceAlert on MSN14h
Nanoparticles Reverse Parkinson's in Mice by Healing Damaged Dopamine CellsStimulating dopamine-producing brain cells wirelessly with gold nanoparticles has proven effective at treating mice with ...
Neurological conditions are now the leading cause of ill health worldwide, yet remain an enigma. Meet the patients who baffle ...
A new collaborative research group, the Breakthrough Consortium for Olfactory Health (BeCOH), brings together charities, patient groups, research institutions, and clinicians, as well as ...
NYSE:DHR) Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research ...
Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback